A potent growth hormone secretagogue that stimulates the pituitary gland. Increases appetite and GH levels with potential effects on body composition.
Preclinical research has explored the effects of GHRP-6 on lean muscle development, fat mass reduction, joint and tissue recovery, and collagen. It may also prevent doxorubicin-induced myocardial and extra-myocardial damage by activating prosurvival pathways.
GHRP-6 is a synthetic hexapeptide ghrelin-receptor (GHS-R1a) agonist that stimulates pulsatile GH release from the anterior pituitary and increases appetite via central ghrelin signaling.
Sermorelin is a synthetic peptide that functions as a growth hormone-releasing hormone analog, stimulating the body's natural production and release of growth hormone. It was initially developed for treating growth hormone deficiency in both children and adults.
100-200 mcgGrowth Hormone Releasing Peptide-2
A growth hormone releasing peptide that stimulates natural GH secretion. Works synergistically with GHRH analogues for enhanced growth hormone release.
100-300 mcgIpamorelin
Ipamorelin is a synthetic protein fragment that stimulates the body's natural growth hormone release by mimicking ghrelin. It is being researched for its potential to improve body composition and aid in tissue repair.
200-300 mcgIbutamoren Mesylate
MK-677 is an orally active, non-peptide compound that functions as a ghrelin receptor agonist and growth hormone secretagogue, leading to increased secretion of growth hormone and insulin-like growth factor 1, potentially enhancing body composition, sleep quality, and bone density.
12.5-25 mg